Stephanie Meyer Email & Phone Number

Brisbane, California, United States

● Spearheaded the restart of lab operations. Created and executed plans to meet timelines to bring lab back to functionality within 3 months. Handled move of capital equipment and calibrations of all instruments. Re-established contact with multiple vendors, coordinated all pipet calibrations, and managed freezer temperature sensors with Senso-Scientific cloud monitoring system. Managed medical waste disposal, lab coat service, lab purchasing and receiving, created POs for bulk orders, ensured invoices were reconciled with accounting team, maintained lot records and inventory of supplies.● Managed service contracts and maintained calendar of operations.● Began EH&S officer and training.● Routinely tested patient samples for biomarkers in the QSant urine test.● Point of contact for patient biopsy slide digitization process with CRO.● Familiarity with Salesforce, EDC entry, and handling of patient samples. ● Certificate of Completion: Ethics and Human Subjects: A Comprehensive Introduction

Brisbane, California, United States

● Managed corporate biospecimen repository.● Primary liaison for multiple external research partners for inbound and outbound transfer of specimens.● Designed and implemented procedures for inventory management and tracking.

Brisbane, California, United States

● Optimized next-generation ELISA-based biomarker tests for kidney health.● Performed proof-of-concept studies for novel biomarker assays.

South San Francisco, California, United States

● Lead for manufacture of nanofiltration membranes and membrane characterization. ● Trained 4 employees● Spearheaded implementation of quality control systems

● R&D project representative at interdepartmental bi-weekly meetings. Presented results regulary.● Developed multiple Receptor Tyrosine Kinase assays and scaled for HTS screening campaigns. Performed cell-based assays looking at GPCR agonists and antagonists.● Mentored newer teammates in assay development and laboratory techniques.

● Developed, validated, and screened compound libraries for 2nd generation ranolazine (RANEXA) evaluation program. Original Ranexa product sales in 2019 totaled $929 million.● Established competitive binding assay for the adenosine A2a receptor and adapted single tube radioactive assays to 96-well format. Screening led to novel A2a receptor agonist that became FDA approved product Lexiscan®, the most widely used pharmacological stress agent for myocardial perfusion imaging. ● Purified the 20S proteasome from bovine brain to homogeneity and established a set of validated fluorogenic assays for the five catalytic activities. Identified a novel family of inhibitors specific for the chymotrypsin-like activity which resulted in two publications.● Performed compound dosing of mice for in vivo studies of inflammation

● Tested peptidomimetic compounds in rat liver homogenates and S9 fractions. Extracted metabolites from extracellular matrices and characterized by HPLC. ● Performed intraperitoneal compound dosing in mice.● Grew Caco-2 cells without antibiotics via aseptic technique. ● Executed active and passive membrane transport assays with Caco-2 cell membrane monolayers. Tested monolayer integrity with TEER measurements.

Certificate, Product Management

Ethics And Human Subjects Protection: A Comprehensive Introduction, Clinical Sample Handling

Bs, Biochemistry

Classes In: Clinical Pharmacokinetics, Project Management, Essentials Of Business, Marketing